Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: One more positive answer [1] (multiple letters)

Gastroenterology

Volumn 125, Issue 3, 2003, Pages 992-993

  Heuman, Douglas M ^a   Mihas, Anastasios A ^a   Giannini, Edoardo ^b   Botta, Federica ^b   Testa, Roberto ^b   Wiesner, Russell H ^c   Freeman, Richard ^c   Ray Kim, W ^c   Kamath, Patrick ^c   Lake, John ^c   Kremer, Walter ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GENOA   (Italy)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE;

BILIRUBIN BLOOD LEVEL; CALCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CTP SCORE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL STANDARD UNIT; LETTER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MELD SCORE; PRIORITY JOURNAL; SCORING SYSTEM; SURVIVAL; TREATMENT PLANNING;

EID: 0041322954     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)01149-1     Document Type: Letter

References (1)

1. R. Wiesner E. Edwards R. Freeman A. Harper R. Kim P. Kamath Model for end-stage liver disease (MELD) and allocation of donor livers Gastroenterology 124 2003 91 96